title: False-positive hepatitis B serology following IVIG therapy: forgotten but not gone!!
authors.forename: Emma
authors.initials: E
authors.lastname: Benton
authors.forename: Kamran
authors.initials: K
authors.lastname: Iqbal
authors.forename: Paul
authors.initials: P
authors.lastname: Wade
authors.forename: Terry
authors.initials: T
authors.lastname: Wong
authors.forename: Emma
authors.initials: E
authors.lastname: Aarons
authors.forename: Richard
authors.initials: R
authors.lastname: Groves
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000075202:Contraindications; D016107:Epidermolysis Bullosa Acquisita / Q000188:drug therapy* / Q000276:immunology*; D005189:False Positive Reactions; D006509:Hepatitis B / Q000175:diagnosis* / Q000276:immunology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000737:chemistry / Q000276:immunology*; D007155:Immunologic Factors / Q000008:administration & dosage; D008297:Male; D008403:Mass Screening / Q000592:standards*; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D000069283:Rituximab